Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
07/2005
07/07/2005WO2005037839A8 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof
07/07/2005WO2005021025A3 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
07/07/2005US20050148598 Trioxane derivatives
07/07/2005US20050148593 Compounds, compositions, and methods
07/07/2005US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury
07/06/2005EP1549652A1 Fused azole-pyrimidine derivatives
07/06/2005EP1549614A2 Vasculostatic agents and methods of use thereof
07/06/2005EP1549156A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
07/06/2005EP1301187B1 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)
07/06/2005CN1634924A Chiral acetal and ketal compounds and their synthesis method and use
07/05/2005US6914276 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device
07/05/2005US6913710 Reactive mesogenic benzodithiophenes
07/05/2005CA2179530C Cyclic polyamines
07/05/2005CA2072541C Heterocyclic compounds, their production and use
06/2005
06/30/2005WO2005058327A1 Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists
06/30/2005WO2005058231A2 Rifamycin analogs and uses thereof
06/30/2005WO2005021548A3 Substituted 8-heteroaryl xanthines
06/30/2005WO2005000852A3 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
06/30/2005US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases
06/30/2005US20050143414 reacting 2-chlorophenylacetic acid or ester with claimed intermediate N,N'-bis-4,5,6,7-tetrahydro-[3,2-c]-thienopyridyl methane which is solid and can be crystallized; optical purity; no byproducts
06/30/2005US20050143327 Used to ameliorate oxidative stress diseases eg neurodegenerative diseases
06/30/2005CA2549001A1 Rifamycin analogs and uses thereof
06/29/2005EP1546371A1 Substrates for o6-alkylguanine-dna alkyltransferase
06/29/2005CN1633434A Imidazo[1, 2-a]pyridine derivative
06/28/2005US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
06/28/2005US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives
06/28/2005US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
06/23/2005WO2005055943A2 Vinorelbine derivatives
06/23/2005WO2005055939A2 Vinca derivatives
06/23/2005US20050137237 Triazolo-epothilones
06/23/2005US20050137189 For therapy of Gram-positive bacterial infection
06/23/2005US20050137188 Heterocyclic compounds
06/23/2005US20050137169 Vinca derivatives
06/23/2005US20050136287 Coupling a boronic acid having a substituent and 2,5-dihalogen-3,4-dinitrothiophen in the presence of a base by adding a Pd-containing catalyst, reducing nitro groups into amino group; reacting intermediate with camphorquinone
06/23/2005DE10355304A1 Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (piperazin-1-yl) -and 8 - ([1,4] diazepan-1-yl) -xanthines, their preparation and their use as medicaments
06/22/2005EP1544200A1 1,2,4 -TRIAZOLO 1,5-c PYRIMIDINE DERIVATIVE
06/22/2005EP1543011A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
06/22/2005EP1543001A1 Novel pyrazolopyridine derivatives as pharmaceutical agents
06/22/2005EP1542690A2 Manzamine-producing actinomycetes
06/22/2005EP1040111B1 Integrin receptor antagonists
06/22/2005CN1630657A Deazapurines and uses thereof
06/22/2005CN1629158A Pyran derivative
06/21/2005US6908913 Carbapenem derivatives
06/16/2005WO2005054248A1 PORPHYRIN/PHTHALOCYANINE DIMER AND TETRAMER DIRECTLY BONDED AT π SYSTEM AND PROCESSES FOR PRODUCING THESE
06/16/2005WO2005054236A1 Substituted quinolines for the treatment of cancer
06/16/2005WO2005044818A3 Imidazo[1,2-a]pyridine anxiolytics
06/16/2005US20050131204 Multifunctional 3,4-alkylenedioxythiophene derivatives and electrically conductive polymers containing them
06/16/2005US20050131015 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
06/16/2005US20050131011 Antiinflammatory agents; viricides against human t-cell/lymphoma virus or retroviruses
06/16/2005US20050130985 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition
06/15/2005EP1541577A1 Multifunctional 3,4-alkylenedioxythiophene-derivatives and electrically conductive polymers containing said compounds
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539168A2 Treatment of neuropathic pain with 6h-pyrrolo(3,4-d)pyridazine compounds
06/15/2005EP1539133A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005CN1626531A Imidazole ring-containing compound and organic electroluminescence display device
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/09/2005WO2005051959A1 Β-lactamase-resistant cephalosporin ester compounds and salts of thereof
06/09/2005WO2005051950A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug
06/09/2005WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives
06/09/2005WO2003088897A3 Fab i inhibitors
06/09/2005US20050124649 Deazapurines and uses thereof
06/09/2005US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma
06/09/2005US20050124646 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
06/09/2005CA2544480A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug
06/08/2005EP1537123A1 Compounds
06/08/2005EP1440075B1 Novel 3beta-amino azabicyclooctane heteroaromatic amide derivatives, preparation method and therapeutic uses thereof
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005CN1625555A Quinazoline compounds
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/02/2005WO2005051046A1 Light-emitting device, organic compound and display
06/02/2005WO2005049582A1 Method of preparation of novel nucleoside analogs and uses
06/02/2005WO2005028480A3 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
06/02/2005WO2005023806A3 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands
06/02/2005US20050119486 Diamine derivatives
06/02/2005US20050119334 Neurodegenerative disease; Alzheimer's and Parkinson's disease
06/02/2005US20050119325 N-(1-azabicyclo[2.2.2]oct-3-yl)-heteroaryl carboxamides; alpha 7-nicotinic acetylcholine receptors (nAChR) agonists; improving perception, concentration, learning and memory; neuropathic pain; acute and chronic pain
06/02/2005US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity
06/02/2005US20050119232 10 alpha -(sulfamino)dihydroartemisinin and Bis[(10 alpha -dihydroartemisinyl)]sulfamide; parasiticide; malaria, neosporosis and coccidiosis; Plasmodium falciparum, Neospora caninum and Eimeria tenella; improved stability, bioavailability, neurotoxicity
06/02/2005US20050119228 Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
06/01/2005EP1219626B1 Compounds for fluorescence labeling
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
05/2005
05/31/2005US6900160 Triazolo-epothilones
05/26/2005WO2005046588A2 Compounds, compositions, and methods
05/26/2005US20050113397 Broad spectrum antifungal agent; 1,6-beta-glucan synthetase inhibitors; pyrido(1,2-a)benzimidazole derivatives or benzo(4,5)imidazo(1,2-a)pyridine derivatives
05/26/2005US20050113379 Corticotropin releasing factor (CRF); affective disorders, anxiety disorders, stress-related disorders, eating disorders and substance abuse; eg 5-(1-Ethyl-propyl)-2-(2-methoxy-4-trifluoromethoxy-phenyl)-3,7-dimethyl-5H-pyrrolo[2,3-b]pyrazine
05/26/2005US20050112407 Organic electroluminescent device
05/25/2005EP1532209A2 Charge transport compositions and electronic devices made with such compositions
05/25/2005EP1532154A1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
05/25/2005EP1532153A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
05/25/2005EP1531811A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
05/25/2005EP0904274B1 Farnesyl transferase inhibitors
05/25/2005EP0836613B1 Water-soluble adenosine kinase inhibitors
05/25/2005CN1620455A Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/25/2005CN1620292A Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
05/24/2005US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors
05/19/2005WO2005044818A2 Imidazo[1,2-a]pyridine anxiolytics
05/19/2005US20050107622 Novel method for wholly synthesizing of ciguatoxin ctx3c derivative
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 111